aschnell001

Vistagen Therapeutics Inc - VTGN

Long
NASDAQ:VTGN   VistaGen Therapeutics, Inc
70 views
0
Based on 4 Wall Street analysts offering 12-month price targets for VistaGen Therapeutics in the last 3 months, the average price target is $7.00 with a high forecast of $9.00 and a low forecast of $5.00. The average price target represents a 123.64% change from the last price of $3.13.